RVMD - Revolution Medicines, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-1.56
|
Rev Est: $3.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$120.27
DETAILS
HIGH:
$170.00
LOW:
$73.00
MEDIAN:
$140.00
CONSENSUS:
$120.27
UPSIDE:
14.73%
Market Cap:
20.27B
Volume:
1,653,933
Avg Volume:
3,310,698
52 Week Range:
29.17-124.49
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.00
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
616
IPO Date:
2020-02-13
EPS (TTM):
-3.58
P/E Ratio:
-12.23
Revenue (TTM):
N/A
Total Assets:
2.56B
Total Debt:
135.84M
Cash & Equiv:
543.06M
Rev Growth (5Y):
-100.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-25.1%
Debt/Equity:
0.06
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-1.61 | $-1.42 | -13.4% | — | $1.7M | — |
| 2025-08-06 | $-1.31 | $-0.94 | -39.4% | — | $27.5M | — |
| 2025-05-07 | $-1.13 | $-1.12 | -0.9% | — | — | — |
| 2025-02-26 | $-1.12 | $-1.01 | -10.9% | $261.6M | $346150 | +75471.9% |
| 2024-11-06 | $-0.94 | $-0.89 | -5.2% | — | $346154 | — |
| 2024-08-07 | $-0.81 | $-0.77 | -5.2% | — | $750000 | — |
| 2024-05-08 | $-0.70 | $-0.75 | +6.2% | — | $1.4M | — |
| 2024-02-26 | $-1.14 | $-0.86 | -32.6% | $742000 | $1.1M | -31.9% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 11.58M | 35.38M | 29.39M | 42.98M | 50.04M | 20.16M | 0 |
| Net Income | (600.09M) | (436.37M) | (248.71M) | (187.09M) | (108.16M) | (47.66M) | (41.79M) | (31.13M) |
| EPS | -3.58 | -3.86 | -3.08 | -2.47 | -1.62 | -1.31 | -1.15 | -0.85 |
| Total Assets | 2.56B | 2.06B | 811.93M | 737.99M | 567.40M | 220.53M | 170.59M | 15.08M |
| Total Debt | 135.84M | 87.94M | 64.20M | 66.63M | 32.66M | 0 | 147,000 | 0 |
| Cash & Equivalents | 543.06M | 696.15M | 161.41M | 108.50M | 104.27M | 16.66M | 69.59M | 9.08M |
| Operating Cash Flow | (557.44M) | (350.57M) | (224.40M) | (147.18M) | (100.06M) | (49.62M) | 1.21M | (25.15M) |
| Free Cash Flow | (567.74M) | (358.30M) | (235.22M) | (153.71M) | (103.00M) | (52.20M) | (286,000) | (26.72M) |
| FCF per Share | -3.38 | -3.17 | -2.92 | -2.11 | -1.55 | -1.43 | -0.01 | -0.73 |
| Book Value | 2.27B | 1.83B | 685.19M | 602.57M | 474.68M | 152.53M | 96.66M | 4.53M |
| Cash & ST Investments | 2.29B | 1.85B | 644.94M | 577.05M | 440.74M | 122.76M | 69.59M | 9.08M |
| ROC Equity | -0.26 | -0.24 | -0.36 | -0.31 | -0.23 | -0.31 | -0.43 | -6.87 |